What is Cagrilintide + Semaglutide Blend?
Cagrilintide + Semaglutide is a dual-peptide research formulation combining an amylin analog (Cagrilintide) with a GLP-1 receptor agonist (Semaglutide).
-
Cagrilintide is a long-acting amylin receptor agonist studied for appetite suppression, gastric emptying modulation, and satiety signaling.
-
Semaglutide is a GLP-1 receptor agonist investigated for its effects on glucose regulation, insulin secretion, and appetite control.
The combination is being explored in metabolic research due to complementary mechanisms: amylin receptor activation enhances satiety and reduces food intake, while GLP-1 receptor activation improves glycemic control and further suppresses appetite.
Research Applications
- Dual amylin/GLP-1 pathway studies
- Enhanced appetite suppression research
- Synergistic weight loss investigation
- Gastric emptying modulation studies
- Combination incretin therapy research
Quick Product Specs
- Form: Lyophilized Powder
- CAS Number: Not applicable (dual peptide combination)
- Molecular Formula: Sequence-specific (Cagrilintide + Semaglutide)
- Storage: -20°C (long-term) / 2–8°C after reconstitution
- Shelf Life: 24 months unopened
- Type: Dual Amylin Analog + GLP-1 Receptor Agonist Blend
-
Composition (per vial)
Cagrilintide – 5 mg
Semaglutide – 5 mg
Certificate of Analysis (COA)

https://verify.janoshik.com/tests/93615-Cagrisema5mg5mg_3WJS514CG6YY




